Two weeks ago I had the opportunity to fly down to New Orleans and speak to a group of oncology nurses on behalf of the Institute for Medical Education and Research (IMER).

I ended Tuesday’s heartfelt, personal post this way:

I need to put details about my own story–and RVD “light,” on hold for a day to discuss some breaking news with you.

Yesterday I closed my post with this cryptic statement:

Did you happen to read the comment from Terry yesterday following my post slamming skeletal surveys?  Just in case you missed it…

I have already heard from several fellow myeloma patients that are willing to share their stories after reading Friday’s post:

Normally I would relegate information like this to my MyelomaNews.com site.  But this is important–really important.

Earlier this week I spoke to a group of 50 nurses near my home here in Florida.

I’ll bet that no one else noticed this feature on Sokolove Law, LLC’s website?

While we were busy being inspired–and reading nutritional tips to help us control our myeloma–there was a lot going on with the new myeloma therapies and the FDA.

Pattie and I drove over to Orlando this weekend to visit Florida’s Universal Resort for the first time.

Pleas read this excerpt from a transcript which is part of a CME credit program for physicians, produced by MedPageTODAY:

I wanted to keep those of you who kindly follow my site updated on my medical journey.

My friend, Richard, from our myeloma support group, is a big-time baseball fan.  He loves spring training, so he talked me into going to a game a couple of weeks ago in Dunedin, Florida.  It’s about an hour drive from my home.  The Toronto Blue Jays were playing the Minnesota Twins.  The park is very retro–a throwback to the days before most spring training ball parks had sky boxes.

We learned a lot about salvage therapy a few days back.   Let’s continue our multiple myeloma education and study the ABCs of therapy for newly diagnosed patients.

One more review of last December’s ASH in San Diego.

A few days back I ran a post about how improvements in the way allogeneic transplants are administered may help reduce the number and severity of side-effects:

Think that something as simple as how a medication is delivered can’t make a significant difference?  Wait until you read about this…

Wow!  This continuing ed course for medical oncologists and hematologists is really interesting!

It was easy to become a bit discouraged as I wrote my book last year, Stem Cell Transplants from a Patient’s Perspective.